The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study to evaluate the safety and efficacy of OQL011 on VEGFR inhibitor-associated hand-foot-skin reaction in cancer patients.
 
Mario E. Lacouture
Stock and Other Ownership Interests - OncoDerm (I)
Honoraria - ADC Therapeutics; Amgen; Apricity Health; AstraZeneca; azitra; azitra; Deciphera; Galderma; Genentech; Janssen; Johnson & Johnson; Kyowa Hakko Kirin; Loxo; Menlo Therapeutics; NCODA; Novartis; Novocure; OnQuality Pharmaceuticals; QED Therapeutics; Roche/Genentech; Seattle Genetics/Astellas; Teva; Teva
Consulting or Advisory Role - Abbvie; Adgero Biopharmaceuticals; Adjucare; Allergan; Amgen; Amryt Pharma; AstraZeneca; Bayer; Biotechspert; Boehringer Ingelheim; Celldex; Debiopharm Group; Dignitana; E.R. Squibb Sons, LLC; EMD Serono; Galderma; Genentech; Janssen Oncology; Janssen Research & Development; Johnson & Johnson; Legacy Healthcare Services; Legacy Healthcare Services; Lindi Skin; Lutris; Manner SAS; Menlo Therapeutics; Merck; Novartis; Novocure; OnQuality Pharmaceuticals; OurBrainBank; Parexel; Paxman; Pierre Fabre; QED Therapeutics; Roche; Roche; Roche; Roche; Seagen; Takeda/Millennium; Teva
Research Funding - Lutris; Novocure; Paxman; US Biotest; Veloce Pharmaceuticals
Travel, Accommodations, Expenses - AstraZeneca; Deciphera; Kyowa Hakko Kirin; Novocure; Teva
Other Relationship - OncoDerm (I)
(OPTIONAL) Uncompensated Relationships - OncoDerm; OncoDerm
 
Milan J. Anadkat
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Amgen; Anthem; Bristol-Myers Squibb; Celgene; CVS Health; Gilead Sciences; Humana; Incyte; Johnson & Johnson; Lilly; Medtronic; Merck; Mylan; Perrigo; Pfizer; Procter & Gamble; Regeneron; Roche; United Health Group; Walgreens Boots Alliance
Honoraria - Abbvie; Adgero Biopharmaceuticals; Boehringer Ingelheim; Novocure; UCB
Consulting or Advisory Role - Adgero Biopharmaceuticals; Boehringer Ingelheim; Novocure
Research Funding - Abbvie (Inst); AnaptysBio (Inst); Biogen (Inst); Boehringer Ingelheim (Inst); InflamRx (Inst); Innovaderm (Inst); Lilly (Inst); Lutris (Inst); Novartis (Inst); OnQuality Pharmaceuticals (Inst); UCB (Inst); Veloce Pharmaceuticals (Inst); XBiotech (Inst)
 
Omkar Subhash Marathe
Research Funding - OnQuality Pharmaceuticals (Inst)
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Merck; Novartis; Pfizer; UpToDate
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Caris Life Sciences; Clovis Oncology; Corvus Pharmaceuticals; Eisai; Genentech/Roche; Janssen Oncology; Merck; Modra Pharmaceuticals; Myovant Sciences; on quality; Pfizer; Tolero Pharmaceuticals
Speakers' Bureau - AstraZeneca; AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Myovant Sciences; Sanofi; Seattle Genetics/Astellas
Research Funding - Endocyte (Inst); Merck (Inst); Suzhou Kintor Pharmaceuticals (Inst); US Oncology (Inst)
Expert Testimony - Novartis
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer/Onyx; Exelixis; Genentech/Roche; Pfizer; Sanofi/Aventis; US Oncology
 
Elaine Tat Lam
Consulting or Advisory Role - Calithera Biosciences
Research Funding - Advaxis (Inst); Amgen (Inst); Argos Therapeutics (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Constellation Pharmaceuticals (Inst); Decibel Therapeutics (Inst); Exelixis (Inst); FORMA Therapeutics (Inst); Harpoon Therapeutics (Inst); Immunomedics (Inst); Merck (Inst); OnQuality Pharmaceuticals (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Phosplatin Therapeutics (Inst); Regeneron (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Decibel Therapeutics
 
Benjamin Kaffenberger
Research Funding - AnaptysBio (Inst); Biogenerix (Inst); InflarxGmbH (Inst); OnQuality Pharmaceuticals (Inst)
 
Jennifer N. Choi
Consulting or Advisory Role - Azitra; Bristol Meyers Squibb; Keratin Biosciences; Kyowa Kirin International; La Roche-Posay; OnQuality Pharmaceuticals; PAREXEL; Regeneron
Speakers' Bureau - Bayer
Research Funding - Incyte (Inst)
 
Mark L. Webb
Employment - OnQuality Pharmaceuticals
Stock and Other Ownership Interests - OnQuality Pharmaceuticals
Travel, Accommodations, Expenses - OnQuality Pharmaceuticals
 
Robert Claude Tyler
Employment - Kiadis Pharma; OnQuality Pharmaceuticals
 
Juegang Ju
Employment - OnQuality Pharmaceuticals
 
Hong Tang
Employment - Astellas Scientific and Medical Affairs Inc; Dendreon; Juno Therapeutics; OnQuality Pharmaceuticals
Leadership - OnQuality Pharmaceuticals
Stock and Other Ownership Interests - BeiGene; Bristol-Myers Squibb; CVS; Salesforce; Teladoc
 
Jie Luo
Employment - OnQuality Pharmaceuticals
Leadership - OnQuality Pharmaceuticals
Stock and Other Ownership Interests - OnQuality Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Both myself and family member hold patents pending. the patent is related to healthcare.
Travel, Accommodations, Expenses - OnQuality Pharmaceuticals
Other Relationship - Shanghai Jiao Tong University; Shanghai Jiao Tong University
 
Anisha Patel
Consulting or Advisory Role - Deciphera; NanOlogy; Novartis; OnQuality Pharmaceuticals
Research Funding - Lutris (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis; OnQuality Pharmaceuticals